Published in:
01-04-2010 | Original Article
Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer
Authors:
Shoji Natsugoe, Masataka Matsumoto, Hiroshi Okumura, Yasuto Uchikado, Tetsuro Setoyama, Ken Sasaki, Toshihide Sakurai, Itaru Omoto, Tetsuhiro Owaki, Hiroyuki Shinchi, Shinichi Ueno, Sumiya Ishigami
Published in:
Langenbeck's Archives of Surgery
|
Issue 4/2010
Login to get access
Abstract
Background
Esophagectomy with three-field lymphadenectomy has been performed for esophageal cancer. Detailed analysis of cause of death and mode of recurrence is required to determine the need for further adjuvant therapy and follow-up.
Materials and methods
A total of 208 patients who underwent esophagectomy through right thoracotomy with three-field lymphadenectomy were enrolled into the present study. Mode of first recurrence was divided into four groups: lymph node, hematogenous, mixed, and local recurrence.
Results
Excluding 16 hospital deaths, the number of deaths and 5-year survival rates were 104 patients and 7.8% for cancer recurrence, 12 patients and 53.8% for second primary cancers in other organs, and 34 patients and 31.0% for causes of death unrelated to carcinoma. In the 104 patients with relapse, 5-year survival rate of patients was 14.3% with lymph node recurrence (n = 29), 9.1% with hematogenous recurrence (n = 32), 3.1% with mixed recurrence (n = 35), and 12.5% with local recurrence (n = 8).
Conclusion
To improve outcomes for esophagectomy with three-field lymphadenectomy, early detection of recurrent disease and regular examination of the entire body for secondary cancer is necessary.